Cani et al., 2008 [37] |
C57bl6/J mice and ob/ob mice C57bl6 background |
72% |
Garidou et al., 2015 [38] |
Wildtype (WT) C57Bl6/J mice, (RORγt−/−) mice, Rag1-deficient (Rag1−/−) mice, OVA-specific TCR transgenic (OTII) mice |
72% |
Tomas et al., 2016 [39] |
mice (C57BL/6JRj, Janvier, France) |
71% |
Agus et al., 2016 [29] |
C57BL/6 mice |
60% |
Amar et al., 2011 [40] |
C57bl6, ob/ob, CD14/, ob/obxCD14/, Myd88/, Nod1/or Nod2/mice |
60% |
Brandsma et al., 2019 [41] |
Female Casp1−/− mice (B6N.129S2-Casp1tm1Flv/J)) and Ldlr−/− mice (B6.129S7-Ldlrtm1Her/J) |
60% |
Chelakkot et al., 2018 [42] |
C57BL/6 mice |
60% |
Crawford et al., 2019 [30] |
Sprague-Dawley rats |
60% |
Guo et al., 2017 [43] |
C57BL/6 mice |
60% |
Hu, Zhang, 2016 [44] |
Toll-like receptor 4 knockout (TLR4−/−) and C57BL/6J (WT) mice |
60% |
Jeong et al., 2019 [45] |
Male C57BL/6 J mice |
60% |
Kawano et al., 2016 [46] |
(M-Ccr2KO) and (Vil-Ccl2KO) mice |
60% |
Kim et al., 2012 [47] |
C57BL/6J and TLR4-deficient C57BL/10ScNJ mice |
60% |
In Kim et al., 2019 [48] |
C57BL/6 mice |
60% |
Li et al., 2019 [49] |
C57BL/6 mice |
60% |
Perez et al., 2019 [50] |
C57BL/6 mice (IL-17RA−/−) |
60% |
Schmid et al., 2015 [51] |
Healthy human |
60% |
Talukdar et al., 2012 [52] |
NE KO, JAX labs B6.129X1–Elanetm1Sds/J mice and WT C57BL/6J mice |
60% |
Wang et al., 2020 [53] |
C57BL/6J mice |
60% |
Gulhane et al., 2016 [54] |
Wild type (WT) C57BL/6 mice |
46% |
de la Serre et al., 2010 [55] |
Male Sprague Dawley rats |
45% |
Kim et al., 2019 [31] |
male C57BL/6 J mice |
45% |
Park et al., 2016 [56] |
ApcMin/+ mice |
45% |
Sen et al., 2017 [57] |
Male Sprague Dawley rats |
45% |
Napier et al., 2019 [58] |
BALB/c mice, C57BL/6 mice |
42% |
Murakami et al., 2016 [59] |
C57/BL6 mice |
40% |
Wan et al., 2019 [60] |
Healthy adults |
40% |
Laugerette et al., 2011 [61] |
C57Bl6/J mice |
37.7% |
Guo et al., 2016 [62] |
C57BL/6J ApoE−/− mice |
37% |